Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 2078-2085, 2007. First published October 25, 2007; 10.1373/clinchem.2007.092692
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 092692.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.092692v1
53/12/2078    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, S. R.
Right arrow Articles by Humphries, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, S. R.
Right arrow Articles by Humphries, S. E.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2007;53:2078-2085.)
© 2007 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

IL18 Haplotypes Are Associated with Serum IL-18 Concentrations in a Population-Based Study and a Cohort of Individuals with Premature Coronary Heart Disease

Simon R. Thompson1, Pamela A. McCaskie2, John P. Beilby3, Joseph Hung4,5, Michelle Jennens3, Caroline Chapman3, Peter Thompson4 and Steve E. Humphries1,a

1 Department of Cardiovascular Genetics, University College London, London, United Kingdom.
2 Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia.
3 Clinical Biochemistry, Western Australia Centre for Pathology and Medical Research, University of Western Australia, Perth, Australia.
4 Sir Charles Gairdner Hospital Campus, Heart Research Institute of Western Australia, Perth, Australia.
5 School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

aAddress correspondence to this author at: Department of Cardiovascular Genetics, University College London, 5 University St., London, WC1E 6JF, United Kingdom. Fax 0207-679-6212; e-mail rmhaseh{at}ucl.ac.uk.

Background: Interleukin (IL)-18 is a proinflammatory cytokine that has been implicated in several diseases, including atherosclerosis, and increased circulating IL-18 concentrations increase risk of future coronary heart disease (CHD). We evaluated the effect of common variation within the IL18 gene on concentrations of circulating IL-18.

Methods: We measured IL-18, by ELISA, in the population-based study group [Carotid Ultrasound Disease Assessment Study (CUDAS)] and a predominantly male cohort with premature cardiovascular disease [Carotid Ultrasound in Patients with Ischaemic Heart Disease (CUPID)]. Using a tagging single-nucleotide polymorphism (SNP) approach that captured >90% of genetic variation, we identified 4 common (>10%) haplotypes.

Results: A common SNP was associated with differences in IL-18 concentrations; in CUDAS individuals carrying 2 copies of the rare allele, concentrations were 13% higher than in those with no copies (P = 0.002). Haplotypes were also associated with significant differences in IL-18 concentrations in CUDAS and CUPID. Haplotype GTATA (frequency 23%) was associated with significantly lower IL-18 than others. In CUDAS, those carrying 2 copies had IL-18 concentrations 15% lower than those carrying no copies (P = 0.002); in CUPID, the difference was 22% (P = 0.004). These associations remained significant after adjustment for age, sex, hypertension, HDL cholesterol, waist-to-hip ratio, and alcohol consumption. Despite being associated with differences in IL-18 concentrations, the haplotypes did not occur at different frequencies in those with or without carotid atherosclerotic plaques.

Conclusions: Variation within IL18 affects IL-18 concentrations in healthy and diseased individuals and thus may influence the pathophysiology of plaques at all stages of CHD progression.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.